Allspring Global Investments
LGND icon

Allspring Global Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Allspring Global Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Sell
51,948
-704
-1% -$166K 0.02% 600
2026
Q1 		$10.5M Sell
52,652
-19,166
-27% -$3.79M 0.02% 671
2025
Q4 		$13.7M Sell
71,818
-36,606
-34% -$7.03M 0.02% 623
2025
Q3 		$19.4M Buy
108,424
+32,379
+43% +$4.81M 0.03% 551
2025
Q2 		$8.64M Sell
76,045
-20,374
-21% -$2.18M 0.01% 766
2025
Q1 		$10.1M Sell
96,419
-3,643
-4% -$412K 0.02% 712
2024
Q4 		$10.7M Sell
100,062
-15,418
-13% -$1.74M 0.02% 735
2024
Q3 		$11.6M Buy
115,480
+16,446
+17% +$1.66M 0.02% 720
2024
Q2 		$8.34M Buy
99,034
+13,839
+16% +$1.1M 0.01% 813
2024
Q1 		$6.23M Buy
85,195
+48,022
+129% +$3.54M 0.01% 900
2023
Q4 		$2.65M Buy
37,173
+18,472
+99% +$1.09M ﹤0.01% 1103
2023
Q3 		$1.12M Sell
18,701
-40,726
-69% -$2.68M ﹤0.01% 1332
2023
Q2 		$4.28M Buy
59,427
+51,639
+663% +$3.87M 0.01% 1038
2023
Q1 		$573K Sell
7,788
-21,194
-73% -$1.51M ﹤0.01% 1561
2022
Q4 		$1.94M Buy
28,982
+24,708
+578% +$1.61M ﹤0.01% 1246
2022
Q3 		$229K Buy
4,274
+1,161
+37% +$68.2K ﹤0.01% 1780
2022
Q2 		$173K Sell
3,113
-17,314
-85% -$983K ﹤0.01% 1858
2022
Q1 		$1.43M Sell
20,427
-8,905
-30% -$646K ﹤0.01% 1685
2021
Q4 		$2.83M Buy
+29,332
New +$2.71M ﹤0.01% 1381

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's LGND Position: Q2 2026 in Review

Allspring Global Investments reduced its Ligand Pharmaceuticals (LGND) stake by 1.3% in Q2 2026, selling an estimated $166K and leaving 51,948 shares worth $16.2M. The position accounts for 0.02% of the portfolio, ranked #600.

Allspring Global Investments first reported a position in LGND in Q4 2021 and has held it in 19 quarters since. The position peaked at $19.4M in Q3 2025. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Allspring Global Investments held 51,948 shares of Ligand Pharmaceuticals worth $16.2M as of Q2 2026.
  • Allspring Global Investments sold 704 Ligand Pharmaceuticals shares in Q2 2026, an estimated $166K.
  • Ligand Pharmaceuticals made up 0.02% of Allspring Global Investments's portfolio in Q2 2026, its #600 holding.
  • Allspring Global Investments first reported a position in Ligand Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Ligand Pharmaceuticals position peaked at $19.4M in Q3 2025.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.